Mass spectrometric measurements of norepinephrine synthesis in man from infusion of stable isotope-labelled L-threo-3, 4-dihydroxyphenylserine
- 1 February 1985
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 36 (5) , 435-442
- https://doi.org/10.1016/0024-3205(85)90255-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Treatment of parkinsonism with L‐thereo‐3, 4‐dihydroxyphenylserineNeurology, 1984
- DL-3,4-threo-DOPS in Parkinson's disease: Effects on orthostatic hypotension and dizzinessJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathyEuropean Journal of Clinical Pharmacology, 1982
- Orthostatic hypotension in familial amyloid polyneuropathyNeurology, 1981
- An improved method for determination of plasma norepinephrine: Isolation by boric acid gel and assay by selected ion monitoringJournal of Mass Spectrometry, 1980
- Characteristics of enzymic decarboxylation of L-threo-3,4-dihydroxyphenylserine using hog renal L-aromatic amino acid decarboxylaseBiochemical Pharmacology, 1978
- Decarboxylation of stereoisomers of 3, 4-dihydroxyphenylserine (DOPS) in vitroFolia Pharmacologica Japonica, 1976
- Inhibition of harmaline tremor induced by L-threo-3, 4-dihydroxyphenylserine, a norepinephrine precursorFolia Pharmacologica Japonica, 1976
- INHIBITORY EFFECT OF (+)THREO-3,4-DIHYDROXY-PHENYLSERINE (DOPS) ON DECARBOXYLATION OF (−)THREO-DOPSThe Japanese Journal of Pharmacology, 1976
- Formation of noradrenaline in the rat brain from the four stereoisomers of 3,4-dihydroxyphenylserineNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1974